Products
Genetic testing of hereditary cancers

Some examples of the common malignant tumors of hereditary nature:

Mammary carcinoma, ovarian cancer, endometrial cancer, colorectal cancer, gastric cancer, gastrointestinal stromal tumors, renal cell carcinoma, pancreatic cancer, bladder cancer, prostate cancer, non-small cell lung cancer, small cell lung cancer.
Chondrosarcoma, desmoid tumor, leiomyosarcoma, tuberous sclerosis, hereditary multiple exostosis.
Thyroid adenocarcinoma, medullary carcinoma of thyroid, parathyroid carcinoma, multiple endocrine neoplasia.
Melanoma, leukemia, non- Hodgkin's lymphoma.
Neuroglioma, pituitary adenoma, retinoblastoma, neurofibromatosis, pheochromocytoma.

Testing cases:

  The first case of the third generation in vitro fertilized infant in China was born in Shanghai via single-cell high-throughput sequencing technique. The infant’s father was a patient with thyroid carcinoma and there is 50% chance to pass his pathogenic gene to the next generation. The medical specialists blocked the opportunity of the spreading of the familial thyroid cancers through genetic screening and sequencing techniques.

  Angelina Jolie’s mother died from breast cancer at age 56. As a family member of high cancer risk to proactively prevent cancer development, Angelina Jolie received genetic testing for driven genes of breast cancers. After knowing she got the genetic mutation of BRCA1 gene from her mother, which increased her risk of suffering from breast cancers before 70 years old by 50~80% and her chance of developing ovarian cancer by up to 24-40%, finally, under the doctor's advices, she accepted a mastectomy and oophorectomy to reduce her risk of developing malignant cancers

about us
about us

Jiuzhou Genetics focuses on the application of high-throughput sequencing and other cutting-edge biotechnologies in human medical and healthcare fields. We concentrate on the field of personal genomics, aiming to provide the best professional services on genetic counseling for Chinese, molecular diagnosis of the highest quality and the world-leading precise individualized treatment regimens as high-end services to our clients. This company was established in September of 2016 and registered in the central Science & Technology Park of Shijingshan region in Beijing.